Proteomic Analysis of Primary Graft Dysfunction in Porcine Lung Transplantation Reveals Alveolar-Capillary Barrier Changes Underlying the High Particle Flow Rate in Exhaled Breath

Transpl Int. 2024 Apr 8:37:12298. doi: 10.3389/ti.2024.12298. eCollection 2024.

Abstract

Primary graft dysfunction (PGD) remains a challenge for lung transplantation (LTx) recipients as a leading cause of poor early outcomes. New methods are needed for more detailed monitoring and understanding of the pathophysiology of PGD. The measurement of particle flow rate (PFR) in exhaled breath is a novel tool to monitor and understand the disease at the proteomic level. In total, 22 recipient pigs underwent orthotopic left LTx and were evaluated for PGD on postoperative day 3. Exhaled breath particles (EBPs) were evaluated by mass spectrometry and the proteome was compared to tissue biopsies and bronchoalveolar lavage fluid (BALF). Findings were confirmed in EBPs from 11 human transplant recipients. Recipients with PGD had significantly higher PFR [686.4 (449.7-8,824.0) particles per minute (ppm)] compared to recipients without PGD [116.6 (79.7-307.4) ppm, p = 0.0005]. Porcine and human EBP proteins recapitulated proteins found in the BAL, demonstrating its utility instead of more invasive techniques. Furthermore, adherens and tight junction proteins were underexpressed in PGD tissue. Histological and proteomic analysis found significant changes to the alveolar-capillary barrier explaining the high PFR in PGD. Exhaled breath measurement is proposed as a rapid and non-invasive bedside measurement of PGD.

Keywords: exhaled breath particles; lung transplantation; mass spectrometry; particle flow rate; primary graft dysfunction.

MeSH terms

  • Animals
  • Breath Tests* / methods
  • Bronchoalveolar Lavage Fluid* / chemistry
  • Exhalation
  • Female
  • Humans
  • Lung Transplantation* / adverse effects
  • Male
  • Primary Graft Dysfunction* / etiology
  • Primary Graft Dysfunction* / metabolism
  • Proteomics* / methods
  • Swine

Grants and funding

The authors gratefully acknowledge funding from: Knut and Alice Wallenberg Foundation, the Marcus and Marianne Wallenberg foundation, Swedish Innovation Agency, the Centre for Advanced Medical Products (CAMP) by the Vinnova Foundation, the ALF Foundation, the Swedish National Infrastructure for Biological Mass Spectrometry.